Table 2

Operative details

Aspect of surgeryOestrogen
(n=44)
No treatment (n=45)
POP surgery performed
 Anterior repair35 (80%)34 (76%)
 Posterior repair16 (36%)19 (42%)
 Vaginal hysterectomy±bilateral salpingo-oophorectomy26 (59%)25 (56%)
 Sacrospinous fixation6 (14%)6 (13%)
Concomitant surgery
 Sling/Tension-free vaginal tape1 (2%)1 (2%)
 Botulinum toxin A1 (2%)1 (2%)
 Suprapublic catheter1 (2%)1 (2%)
Ease of dissection
 Very easy6 (14%)5 (11%)
 Easy22 (50%)13 (29%)
 Normal14 (%)21 (47%)
 Difficult2 (5%)5 (11%)
 Very difficult0 (-)1 (2%)
Blood loss (g)
 N; median (IQR)n=44;
63 (50–125)
n=44;
54 (50–100)
 Missing0 (-)1 (2%)
Visceral injury
 Bladder injury0 (-)0 (-)
 Urethral injury0 (-)0 (-)
 Ureteric injury1 (2%)0 (-)
 Bowel injury0 (-)0 (-)
 Button hole of vagina3 (7%)1 (2%)
Suture used—fascial plication*
 Polyglactin (Vicryl, Ethicon/Polysorb, Medtronic)10 (23%)10 (22%)
 Polydioxanone (PDS-II, Ethicon)35 (80%)34 (76%)
 Poligelcarprine (Monocryl, Ethicon)0 (-)0 (-)
 Missing01
Suture used—Vagina*
 Polyglactin (Vicryl, Ethicon/Polysorb, Medtronic)41 (93%)42 (93%)
 Polydioxanone (PDS-II, Ethicon)5 (11%)6 (13%)
 Poligelcarprine (Monocryl, Ethicon)3 (7%)1 (2%)
 Vaginal packing used23 (52%)28 (62%)
Cather inserted in theatre
 Yes43 (98%)42 (93%)
Postoperative complications noted before discharge
 Infection1 (2%)3 (7%)
 Ureteric injury0 (-)0 (-)
 Bladder injury0 (-)0 (-)
 Bowel injury0 (-)0 (-)
 Vascular injury0 (-)0 (-)
 Neurological injury0 (-)0 (-)
 Perioperative or postoperative blood transfusion0 (-)0 (-)
 Perioperative or postoperative thromboembolism0 (-)0 (-)
 Death0 (-)0 (-)
  • *More than one can be selected, hence numbers do not add up to total.

  • POP, pelvic organ prolapse.